Logo image of UBI.PA

UBISOFT ENTERTAINMENT (UBI.PA) Stock Fundamental Analysis

EPA:UBI - FR0000054470 - Common Stock

8.794 EUR
-0.03 (-0.36%)
Last: 9/4/2025, 5:29:56 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to UBI. UBI was compared to 42 industry peers in the Entertainment industry. The financial health of UBI is average, but there are quite some concerns on its profitability. UBI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year UBI has reported negative net income.
UBI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: UBI reported negative net income in multiple years.
UBI had a positive operating cash flow in each of the past 5 years.
UBI.PA Yearly Net Income VS EBIT VS OCF VS FCFUBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

The Return On Assets of UBI (-3.38%) is comparable to the rest of the industry.
UBI's Return On Equity of -8.86% is in line compared to the rest of the industry. UBI outperforms 52.38% of its industry peers.
Industry RankSector Rank
ROA -3.38%
ROE -8.86%
ROIC N/A
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
UBI.PA Yearly ROA, ROE, ROICUBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

UBI has a Gross Margin of 89.33%. This is in the better half of the industry: UBI outperforms 78.57% of its industry peers.
In the last couple of years the Gross Margin of UBI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for UBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
UBI.PA Yearly Profit, Operating, Gross MarginsUBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

UBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UBI has been increased compared to 1 year ago.
Compared to 5 years ago, UBI has more shares outstanding
The debt/assets ratio for UBI has been reduced compared to a year ago.
UBI.PA Yearly Shares OutstandingUBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
UBI.PA Yearly Total Debt VS Total AssetsUBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

UBI has an Altman-Z score of 1.12. This is a bad value and indicates that UBI is not financially healthy and even has some risk of bankruptcy.
UBI has a Altman-Z score (1.12) which is comparable to the rest of the industry.
The Debt to FCF ratio of UBI is 2.24, which is a good value as it means it would take UBI, 2.24 years of fcf income to pay off all of its debts.
UBI has a Debt to FCF ratio of 2.24. This is in the better half of the industry: UBI outperforms 69.05% of its industry peers.
A Debt/Equity ratio of 1.02 is on the high side and indicates that UBI has dependencies on debt financing.
UBI's Debt to Equity ratio of 1.02 is in line compared to the rest of the industry. UBI outperforms 40.48% of its industry peers.
Even though the debt/equity ratio score it not favorable for UBI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.24
Altman-Z 1.12
ROIC/WACCN/A
WACC5.2%
UBI.PA Yearly LT Debt VS Equity VS FCFUBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.68 indicates that UBI should not have too much problems paying its short term obligations.
UBI has a better Current ratio (1.68) than 85.71% of its industry peers.
A Quick Ratio of 1.68 indicates that UBI should not have too much problems paying its short term obligations.
The Quick ratio of UBI (1.68) is better than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.68
UBI.PA Yearly Current Assets VS Current LiabilitesUBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

The earnings per share for UBI have decreased strongly by -131.28% in the last year.
The Revenue for UBI has decreased by -17.46% in the past year. This is quite bad
Measured over the past years, UBI shows a small growth in Revenue. The Revenue has been growing by 3.56% on average per year.
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%

3.2 Future

UBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.67% yearly.
The Revenue is expected to grow by 5.20% on average over the next years.
EPS Next Y30.99%
EPS Next 2Y75.56%
EPS Next 3Y55.72%
EPS Next 5Y33.67%
Revenue Next Year-4.24%
Revenue Next 2Y4.07%
Revenue Next 3Y4.66%
Revenue Next 5Y5.2%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UBI.PA Yearly Revenue VS EstimatesUBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
UBI.PA Yearly EPS VS EstimatesUBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

UBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UBI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UBI.PA Price Earnings VS Forward Price EarningsUBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UBI is valued a bit cheaper than 78.57% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UBI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.21
EV/EBITDA 3.44
UBI.PA Per share dataUBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as UBI's earnings are expected to grow with 55.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.56%
EPS Next 3Y55.72%

0

5. Dividend

5.1 Amount

UBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UBISOFT ENTERTAINMENT

EPA:UBI (9/4/2025, 5:29:56 PM)

8.794

-0.03 (-0.36%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-22 2025-07-22
Earnings (Next)10-28 2025-10-28
Inst Owners36.11%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.17B
Analysts55.24
Price Target11.42 (29.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.07%
PT rev (3m)-30.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-144.94%
EPS NY rev (3m)-144.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-13.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.61
P/FCF 1.21
P/OCF 1.16
P/B 0.65
P/tB N/A
EV/EBITDA 3.44
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)7.29
FCFY82.93%
OCF(TTM)7.61
OCFY86.52%
SpS14.32
BVpS13.54
TBVpS-3.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.38%
ROE -8.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.33%
FCFM 50.92%
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.24
Debt/EBITDA 2.7
Cap/Depr 5.9%
Cap/Sales 2.21%
Interest Coverage N/A
Cash Conversion 148.22%
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.68
Altman-Z 1.12
F-Score3
WACC5.2%
ROIC/WACCN/A
Cap/Depr(3y)8.81%
Cap/Depr(5y)10.92%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
EPS Next Y30.99%
EPS Next 2Y75.56%
EPS Next 3Y55.72%
EPS Next 5Y33.67%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%
Revenue Next Year-4.24%
Revenue Next 2Y4.07%
Revenue Next 3Y4.66%
Revenue Next 5Y5.2%
EBIT growth 1Y-109.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1517.96%
EBIT Next 3Y172.46%
EBIT Next 5Y83.66%
FCF growth 1Y129.47%
FCF growth 3Y16.28%
FCF growth 5Y14.31%
OCF growth 1Y87.67%
OCF growth 3Y12.65%
OCF growth 5Y10.94%